2. Investigations
1. Urine glucose : Glycosuria – low threshold , drugs
2. Blood glucose : Venous plasma glucose
Diabetes :- fasting > 126mg% , 2 hrs after 75 gm glucose or
random sample >200 mg% , Or
Pre diabetes :- IFG > 110 - < 126 mg% , IGT 2 hrs after 75
gm glucose 140 - 200 mg% , Or
Hba1c > 6.55%
In asymptomatic patients two diagnostic tests(same) are required to confirm
diabetes
3.
4. Inv contd…
OGTT
Preparation before the test
Unrestricted carbohydrate diet for 3 days
Fasted overnight for at least 8 hours
Rest for 30 minutes
Remain seated for the duration of test with no smoking
Sampling
Measure plasma glucose before and 2 hours after a 75 gm glucose drink
5. inv contd…
Blood test :
Enzymatic reaction (glucose oxidase) , cheap , automated , reliable
depends on timing of meal.
Testing sticks read with portable electronic meter (capillary/finger prick)
Testing for control only for those on sulphonylureas /insulin
For diagnosis: accurate lab method
Venous plasma values are most reliable for diagnostic purposes
6. Interstitial glucose :- CGM systems – tiny sensor under skin (measures
every 1-5 min) , life : 2 weeks . Night time glucose level.
Ketones(Urine & blood ) :- acetoacetate identified by nitroprusside
reaction in urine. Do not measure major ketone found in blood. Also
found in fasting , strenuous exercise , repeated vomiting , diet high fat
low carb.
Major ketone beta(OH)butyric acid found in blood during DKA
detected by stick/electronic meter . useful for management , detection
& prevention in DKA
7. Inv(ketones) Contd…
measurement
<0.6mmol/l
(10mg%)
0.6-1.5mmol/l
(10-27mg%)
1.5-3mmol/l
(27-54mg%)
>3.0mmol/l
(>54mg%)
Interpretation
Normal: no action
Suggest metabolic going down
Risk of DKA with high blood glucose
Severe ketosis : seek urgent medical help
8. Inv contd…
Glycated Hb : accurate & objective measure of glycaemic control over
weeks – months. Non enzymatic covalent attachment of glucose to Hb
Islet antibodies :- high titre islet antibodies suggest type 1 DM.
antibodies against components of islets – insulin , glutamic acid
decarboxylase(GAD) , protein tyrosine phosphatase – related proteins (ia-
2) and Zn transporter ZnT8.
C-peptide :- marker for endogenous insulin. Very low in long standing
type 1DM & very high in severe insulin resistance.
Urine proteins :- micro albuminuria - indicator of diabetic nephropathy
/ risk of macrovascular disease.
9. Aetiology & Pathogenesis
In both types interplay of environmental factors with genetics decide who &
when.
Type 1 DM :- autoimmune destruction of β cells based on model by Eisenbarth
genetically susceptible individual exposed to environmental trigger
β cell autoimmunity progressive loss of β cells.
initially fast first phase insulin secretion loss IGT & undiagnosed DM
Pathology– inflammatory lesion ‘insulitis’-β cell specific.
molecular mimicry, oxidative stress, viral infection
auto-ab : 20-25%-single type,50-60% double , 70% three type.
11. Contd…
Genetic predisposition: –
strong but complex multifactorial ,
monozygotic twins 30-50% concordance ,
dizygotic 6-10%
1:20 in 1st degree relative, 1:300 in general
1-4% (mother), 10% (father) still 80-85% in general
inheritance polygenic -20 regions in human genome
HLA region – MHC short arm chromosome 6
12. Contd…
Environmental predisposition –
Wide geographical & seasonal variation & rapid acquisition in migrants.
Environmental factor : 1-viruses 2- food 3- bovine serum albumin 4 - vit D.
‘hygiene hypothesis’
Metabolic disturbance – type1 DM present on crossing a threshold β cell
destruction. Resulting high glucose may be toxic to ↑β cell.
Hyperglycaemia glycosuria & dehydration fatigue, polyuria , nocturia ,
thirst , polydipsia , infection (UTI) , tachycardia , hypotension , unrestricted
lipolysis & proteolysis weight loss
14. Contd…
Ketoacidosis –
When generation exceeds metabolic capacity
Duration of symptoms : short (few weeks).
Type 1 DM in adults : slow onset type1 diabetes or latent
autoimmune diabetes of adulthood (LADA). Presence of islet ab in
high titre(usually GAD antibody) without rapid progression to insulin
therapy.
Initially managed as type 2 DM but eventually require insulin.
15. Contd…
Type 2 DM : diagnosis of exclusion , highly heterogenous group
initially insulin resistance -- increased insulin secretion – eventual beta cell
failure.
one group– young – insulin resistance due to obesity ,ethnicity
second group – old -- nonobese – pronounced beta cell failure
key feature relative insulin deficiency
18. Contd…
Insulin resistance & metabolic syndrome
often have hypertension , dyslipidaemia (high LDL , TG, low HDL) , NAFLD ,
PCOD .
much more common in obese people
Cause of insulin resistance –
1- central obesity – active adipocyte – FFA – compete with glucose
adipokine like cytokine – on liver & muscle receptors – insulin resistance
19. Contd …
2-- physical activity
inactivity – downregulation insulin sensitive kinase—FFA accumulation
3– Deposition of fat in liver – NAFLD – NASH – cirrhosis .
Pancreatic β cell failure
Early stage: modest decrease in beta cell mass.
At diagnosis- 50% decrease and decline thereafter.
Amyloid deposition
Increased FFA & glucose toxic effect on βcell impaired insulin secretion.
20. Contd…
Genetic predisposition
monozygotic twins : 100 % concordance
over 70 genes/gene regions are associated in beta cell function / turnover
& regulation of cell cycle.
powerful influence by environmental factors.
Environmental factors
overeating ,obesity , decreased activity , age (70%>50 yrs) , ethnicity
21. Contd…
Metabolic disturbances in type 2 DM :
Slow onset relative insulin deficiency
In contrast to type 1, lipolysis & proteolysis not unrestrained – wt.
loss & ketoacidosis seldom occurs
Hyperglycaemia develops over years
At diagnosis – asymptomatic , fatigue over many months ± osmotic
Sx , some spiral decline –DKA, ketosis prone Flatbush syndrome